z-logo
open-access-imgOpen Access
Systemic Candidiasis and Cytomegalovirus Infection in the Setting of Artificial Cardiac Device Deployment
Author(s) -
Manoj Thangam,
Bindu Akkanti,
Maan Malahafio,
Sriram Nathan,
Indranee Rajapreyar,
Pranav Loyalka,
Biswajit Kar,
Igor D. Gregorič
Publication year - 2015
Publication title -
˜the œvad journal
Language(s) - English
Resource type - Journals
ISSN - 2378-2706
DOI - 10.14434/vad.v1i0.27929
Subject(s) - immune system , medicine , immunology , cytomegalovirus , viremia , population , fungemia , intensive care medicine , ventricular assist device , heart failure , mycosis , virus , herpesviridae , viral disease , environmental health
Heart failure is a serious cause of morbidity and mortality worldwide. The advent of implantable cardiac assist devices has generated a new arsenal for treating severe heart failure. However, the potential ramifications of ventricular assist device (VAD) usage are not fully understood. Immune modulation resulting from VAD implantation is an area of growing research. Although we do not fully understand the mechanisms contributing to host immune alteration, changes in cytokine concentrations, deceased lymphocyte activity, and the local effects of device materials have been shown to down regulate immune function. Infection is a serious complication that affects prognosis in this patient population. Malnutrition, critical status, and cardiovascular stress are additional predisposing factors in this fragile group. Driveline and surgery-associated infections are the most commonly identified culprits. However, decreased host immune function facilitates atypical infections including systemic fungemia and viremia. This case is an interesting example of a VAD associated immune system compromise.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here